ICON plc | Clinical Research Organisation (CRO) for Drug Development

Healthcare Intelligence

Clinical Research. Evolved.

Learn more

Beyond buzzwords: Diversity, equity and inclusion in rare disease clinical trials

Read the whitepaper

Evidence Synthesis

A solution to sparse evidence, heterogeneous studies, and disconnected networks

Read the whitepaper
Fortifying vaccines: Preparation and prevention against future infectious disease epidemics

Fortifying vaccines

Preparation and prevention against future infectious disease epidemics.

Sponsor and CRO pharmacovigilance and safety alliances

Sponsor and CRO pharmacovigilance and safety alliances

Outsourcing pharmacovigilance activities.

A guide to safety data migrations

A guide to safety data migrations

Choosing the best approach to maintain data integrity.

Spotlight on regulatory reforms in China

Spotlight on regulatory reforms in China

Although China’s regulatory reforms have attracted many foreign companies to conduct trials in China, there are still challenges.

Featured Services

Seeking parallel consultation from regulators and HTA bodies in Europe

Market Access

Expertise in mission-critical pricing, market access, and reimbursement. 

Site & Patient Solutions

Site & Patient Solutions

Transforming recruitment through patient-centric trials and real-world, real-time data.

Biotech

Biotech

ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.

Functional Resourcing

Functional Resourcing

From recruitment of a single clinical professional to managing entire global functions.

Increasing Site and Patient Compliance

Increasing Site and Patient Compliance

FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.

ICON Insights

What’s happening in ICON